Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans

Radiotherapy and Oncology

Volumn 112, Issue 3, 2014, Pages 430-436

  Kierkels, Roel G J ^a   Korevaar, Erik W ^a   Steenbakkers, Roel J H M ^a   Janssen, Tomas ^b   Van'T Veld, Aart A ^a   Langendijk, Johannes A ^a   Schilstra, Cornelis ^a,c   Van Der Schaaf, Arjen ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Radiotherapeutic Institute Friesland   (Netherlands)

Author keywords

Head and neck cancer; IMRT; Multivariable; NTCP models; Pareto fronts; Plan optimisation

Indexed keywords

CETUXIMAB;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MULTIMODALITY CANCER THERAPY; NORMAL TISSUE COMPLICATION PROBABILITY; RADIATION DOSE DISTRIBUTION; RADIOTHERAPY PLANNING SYSTEM; VERY ELDERLY; XEROSTOMIA; COMPUTER ASSISTED RADIOTHERAPY; FEASIBILITY STUDY; HEAD AND NECK NEOPLASMS; MIDDLE AGED; PROBABILITY; PROCEDURES; RADIATION DOSE; REPRODUCIBILITY; THEORETICAL MODEL;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROBABILITY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; REPRODUCIBILITY OF RESULTS;

EID: 84910154298     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.08.020     Document Type: Article

References (33)

1. J.A. Langendijk, P. Doornaert, I.M. Verdonck-de Leeuw, C.R. Leemans, N.K. Aaronson, and B.J. Slotman Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
2. A.B. Jensen, O. Hansen, K. Jorgensen, and L. Bastholt Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer Acta Oncol 33 1994 487 491
3. P. Dirix, and S. Nuyts Evidence-based organ-sparing radiotherapy in head and neck cancer Lancet Oncol 11 2010 85 91
4. K.S. Chao, N. Majhail, and C.J. Huang Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques Radiother Oncol 61 2001 275 280
5. J. Staffurth Radiotherapy Development Board A review of the clinical evidence for intensity-modulated radiotherapy Clin Oncol (R Coll Radiol) 22 2010 643 657
6. C.M. Nutting, J.P. Morden, and K.J. Harrington Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
7. C.C. Ling, and X.A. Li Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity Med Phys 32 2005 2189 2192
8. X. Allen Li, M. Alber, and J.O. Deasy The use and QA of biologically related models for treatment planning: short report of the TG166 of the therapy physics committee of the AAPM Med Phys 39 2012 1386 1409
9. G.J. Kutcher, and C. Burman Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method Int J Radiat Oncol Biol Phys 16 1989 1623 1630
10. A. Niemierko A generalized concept of equivalent uniform dose (EUD) Med Phys 26 1999 1100
11. X.S. Qi, V.A. Semenenko, and X.A. Li Improved critical structure sparing with biologically based IMRT optimization Med Phys 36 2009 1790 1799
12. N. Anderson, C. Lawford, V. Khoo, M. Rolfo, D.L. Joon, and M. Wada Improved normal tissue sparing in head and neck radiotherapy using biological cost function based-IMRT Technol Cancer Res Treat 10 2011 575 583
13. T. Dirscherl, J. Alvarez-Moret, and L. Bogner Advantage of biological over physical optimization in prostate cancer? Z Med Phys 21 2011 228 235
14. M. Hartmann, and L. Bogner Investigation of intensity-modulated radiotherapy optimization with gEUD-based objectives by means of simulated annealing Med Phys 35 2008 2041 2049
15. Q. Wu, D. Djajaputra, Y. Wu, J. Zhou, H.H. Liu, and R. Mohan Intensity-modulated radiotherapy optimization with gEUD-guided dose-volume objectives Phys Med Biol 48 2003 279 291
16. C. Thieke, T. Bortfeld, A. Niemierko, and S. Nill From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning Med Phys 30 2003 2332 2339
17. L. Jones, and P. Hoban A comparison of physically and radiobiologically based optimization for IMRT Med Phys 29 2002 1447 1455
18. V.A. Semenenko, B. Reitz, E. Day, X.S. Qi, M. Miften, and X.A. Li Evaluation of a commercial biologically based IMRT treatment planning system Med Phys 35 2008 5851 5860
19. I. Beetz, C. Schilstra, and F.R. Burlage Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors Radiother Oncol 105 2012 86 93
20. I. Beetz, C. Schilstra, and A. van der Schaaf NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors Radiother Oncol 105 2012 101 106
21. M.E. Christianen, C. Schilstra, and I. Beetz Predictive modelling for swallowing dysfunction after primary (chemo) radiation: results of a prospective observational study Radiother Oncol 105 2012 107 114
22. J.A. Langendijk, P. Lambin, D. De Ruysscher, J. Widder, M. Bos, and M. Verheij Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach Radiother Oncol 107 2013 267 273
23. H.P. van der Laan, M.E. Christianen, H.P. Bijl, C. Schilstra, and J.A. Langendijk The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study Radiother Oncol 103 2012 76 81
24. M.E. Christianen, J.A. Langendijk, H.E. Westerlaan, T.A. van de Water, and H.P. Bijl Delineation of organs at risk involved in swallowing for radiotherapy treatment planning Radiother Oncol 101 2011 394 402
25. T.A. van de Water, H.P. Bijl, H.E. Westerlaan, and J.A. Langendijk Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia Radiother Oncol 93 2009 545 552
26. D.L. Craft, T.F. Halabi, H.A. Shih, and T.R. Bortfeld Approximating convex Pareto surfaces in multiobjective radiotherapy planning Med Phys 33 2006 3399 3407
27. T. Janssen, Z. van Kesteren, G. Franssen, E. Damen, and C. van Vliet Pareto fronts in clinical practice for pinnacle Int J Radiat Oncol Biol Phys 85 2013 873 880
28. B. Hårdemark, A. Liander, H. Rehbinder, and J. Löf Direct machine parameter optimization with RayMachine in Pinnacle3 2003 RaySearch Laboratories AB
29. ICRU. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT) [ICRU report 83]. J ICRU 2010;10:1-106.
30. A.L. Hoffmann, D. den Hertog, A.Y. Siem, J.H. Kaanders, and H. Huizenga Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects Phys Med Biol 53 2008 6345 6362
31. A. Brahme Optimized radiation therapy based on radiobiological objectives Semin Radiat Oncol 9 1999 35 47
32. J.O. Deasy, V. Moiseenko, L. Marks, K.S. Chao, J. Nam, and A. Eisbruch Radiotherapy dose-volume effects on salivary gland function Int J Radiat Oncol Biol Phys 76 2010 S58 S63
33. C.J. Xu, A. van der Schaaf, C. Schilstra, J.A. Langendijk, and A.A. van't Veld Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models Int J Radiat Oncol Biol Phys 82 2012 e677 e684